Culturally adapted EMDR therapy for major depression in Pakistan
Developing a Culturally and Methodologically Adapted EMDR Protocol for the Treatment of Major Depressive Disorder and Determining Its Efficacy by Testing it Through Online and Face-to-face Modes of EMDR Therapy
This study is testing a new version of EMDR therapy to see if it can help people with major depression in Pakistan, using both in-person and online sessions.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 20 Years to 50 Years |
| Sex | All |
| Sponsor | Khushal Khan Khattak Univeristy, Karak, Pakistan Academic / other |
| Locations | 1 site (Kohat) |
| Trial ID | NCT06439043 on ClinicalTrials.gov |
What this trial studies
This study aims to develop a culturally and methodologically adapted protocol for Eye Movement Desensitization and Reprocessing (EMDR) therapy to treat Major Depressive Disorder (MDD) in Pakistan. It will evaluate the efficacy of both in-person and online EMDR modalities through a randomized controlled trial involving 90 participants. The study seeks to address the cultural appropriateness of EMDR, which originated in the U.S., and assess its effectiveness in a non-Western context. By employing a mixed-methods approach, the research will gather qualitative and quantitative data to inform future adaptations of EMDR therapy.
Who should consider this trial
Good fit: Ideal candidates for this study are males and females aged 20 to 50 who exhibit symptoms of Major Depressive Disorder and are treatment-naïve.
Not a fit: Patients with significant neuropsychological or cognitive disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective and culturally relevant treatment option for patients suffering from Major Depressive Disorder in Pakistan.
How similar studies have performed: While adaptations of EMDR in non-Western contexts are limited, similar studies have shown promise in culturally tailoring psychotherapeutic approaches, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The patient should exhibit symptoms of Major Depressive Disorder. 2. Male and female patients will be chosen equally. 3. Patients between the ages of 20 and 50 will be selected. 4. Patients should preferable be "treatment-naïve," meaning they have no recent history of any psychotherapy or medication. Exclusion Criteria: a. There must be no significant neuropsychological or cognitive disorders among the patients
Where this trial is running
Kohat
- KKKUk — Kohat, Pakistan (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.